ELi rahvatervise juhtimine

Improving health systems

Hea tervise edendamine

Medical devices

Substances of human origin

Veri, koed ja elundid

Farmaatsiatooted

Haigustevastased meetmed

Riskihindamine

Teaduskomiteed

Endocrine disruptors

Endocrine disruptors

Biocides

Biocides

Konsultatsioonid

Open consultations

28 September - 21 Detsember 2021

Revision of the EU general pharmaceuticals legislation

Closed consultations

31 August - 15 Oktoober 2021

Targeted stakeholder consultation on the amendments to Commission Implementing Regulation (EU) 520/2012 on pharmacovigilance activities
07 Mai - 30 Juuli 2021

Medicines for children & rare diseases – updated rules
10 - 19 Märts 2021

Structured Dialogue initiative - Recruitment
24 November 2020 - 05 Jaanuar 2021

Impact assessment – EU legislation on medicines for rare diseases and paediatric medicines
22 Juuni - 22 Juuli 2020

Targeted stakeholder consultation on the pilot project ‘Market Launch Intentions of Centrally Authorised Products’
16 Juuni - 15 September 2020

Pharmaceuticals – safe and affordable medicines (new EU strategy)
02 Juuni - 07 Juuli 2020

Pharmaceutical Strategy Roadmap
20 Märts - 20 Juuni 2020

Targeted stakeholders' consultation on Annex 21: Importation of medicinal products, of the Eudralex volume 4
20 Veebruar - 20 Mai 2020

Second targeted stakeholders' consultation on the revision of Annex 1, on manufacturing of sterile medicinal products, of Eudralex volume 4
29 Jaanuar - 28 Aprill 2019

Targeted consultation on the guideline on the format and content of applications for designation as orphan medicinal products and on the transfer of designations from one sponsor to another

Pages